MENU
INMB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
INmune Bio (INMB) Ownership - Who owns INmune Bio?
INmune Bio Inc is a clinical-stage biotechnology company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
225 NE Mizner Boulevard
Phone
+1 858 964-3720
Employees
17
Web
https://www.inmunebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
178.04M
P/E Ratio
N/A
Total Cash
33.55M
Projected Growth
N/A
Total Debt
2.91M
Revenue
42K
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash/Share
1.51
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
INMB
Capitalization
178M
P/E Ratio
N/A
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash
33.6M
Total Cash/Share
1.51
Total Debt
2.91M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
42K
ROE
N/A
Book Value
38.7M
P/B Ratio
4.44
Cash Flow
N/A
Earnings
-2.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
22K
Current Ratio
2.59
Current Revenue Per Employee
823.53
Dividends Per Share - Security
N/A
EBITDA
-41.55M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-71.48
Shares Held By Institutions
43M
Shares Outstanding - Current
22.2M
Total Liabilities
14.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
65.739
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapies that harness the patient's immune system to treat cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 NE Mizner Boulevard
Phone
+1 858 964-3720
Employees
17
Web
https://www.inmunebio.com